[CRVS] QoQ Quarter Result on 31-Mar-2023 [#Q1]

Stock
[CRVS] Corvus Pharmaceuticals, Inc.
Announcement Date
08-May-2023
Financial Year
2023
Quarter
31-Mar-2023 [#Q1]
Profit Trend
QoQ- 45.70%
YoY- 4.19%
Quarter Report
CRVS's Result
CRVS's Financial Summary
View:
Show?
Quarter Result
31/12/23 30/09/23 30/06/23 31/03/23 31/12/22 30/09/22 30/06/22 CAGR
Revenue 246 0 0 0 0 0 0 -
PBT -6,653 -6,000 -6,503 -7,873 -9,816 -14,831 -8,363 -14.10%
Tax -95 -425 -403 923 6,384 -225 -100 -3.35%
NP -6,653 -6,000 -6,503 -8,796 -16,200 -14,831 -8,263 -13.41%
Tax Rate - - - - - - - -
Total Cost 6,899 6,000 6,503 8,796 16,200 14,831 8,263 -11.30%
Ratio Analysis
31/12/23 30/09/23 30/06/23 31/03/23 31/12/22 30/09/22 30/06/22 CAGR
NP Margin -2,704.47 0.00 0.00 0.00 0.00 0.00 0.00 -
Per Share
31/12/23 30/09/23 30/06/23 31/03/23 31/12/22 30/09/22 30/06/22 CAGR
EPS -0.14 -0.12 -0.14 -0.19 -0.35 -0.32 -0.18 -15.38%
EPS Diluted -0.14 -0.12 -0.14 -0.19 -0.35 -0.32 -0.18 -15.38%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.